Cardiovascular Disease and Hemodialysis
Funding
Conflicts of Interest
References
- Jankowski, J.; Floege, J.; Fliser, D.; Böhm, M.; Marx, N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation 2021, 143, 1157–1172. [Google Scholar] [CrossRef] [PubMed]
- Schuett, K.; Marx, N.; Lehrke, M. The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy. Circ. Res. 2023, 132, 902–914. [Google Scholar] [CrossRef] [PubMed]
- Schamroth Pravda, M.; Cohen Hagai, K.; Topaz, G.; Schamroth Pravda, N.; Makhoul, N.; Shuvy, M.; Benchetrit, S.; Assali, A.; Pereg, D. Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis. Am. J. Nephrol. 2020, 51, 635–640. [Google Scholar] [CrossRef] [PubMed]
- Einbinder, Y.; Shnaider, A.; Ghanayem, K.; Basok, A.; Rogachev, B.; Lior, Y.; Haviv, Y.S.; Cohen-Hagai, K.; Nacasch, N.; Rozenberg, I.; et al. Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality. Am. J. Nephrol. 2020, 51, 852–860. [Google Scholar] [CrossRef] [PubMed]
- Erez, D.; Fanadka, F.; Benchetrit, S.; Cohen-Hagai, K. The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients. Am. J. Nephrol. 2021, 52, 763–770. [Google Scholar] [CrossRef] [PubMed]
- Doan, Q.V.; Gleeson, M.; Kim, J.; Borker, R.; Griffiths, R.; Dubois, R.W. Economic burden of cardiovascular events and fractures among patients with end-stage renal disease. Curr. Med. Res. Opin. 2007, 23, 1561–1569. [Google Scholar] [CrossRef] [PubMed]
- Nakić, D.; Grbić Pavlović, P.; Vojković, M.; Stipćević, M.; Patrk, J.; Bištirlić, M.; Bakotić, Z.; Vučak Lončar, J.; Gusar, I. Coronary Artery Disease in Patients on Dialysis: Impact of Traditional Risk Factors. Medicina 2024, 60, 1251–1266. [Google Scholar] [CrossRef] [PubMed]
- Cohen-Hagai, K.; Benchetrit, S.; Wand, O.; Grupper, A.; Shashar, M.; Solo, O.; Pereg, D.; Zitman-Gal, T.; Haskiah, F.; Erez, D. The Clinical Significance of LDL-Cholesterol on the Outcomes of Hemodialysis Patients with Acute Coronary Syndrome. Medicina 2023, 59, 1312–1325. [Google Scholar] [CrossRef] [PubMed]
- Dragoș, D.; Timofte, D.; Georgescu, M.-T.; Manea, M.-M.; Vacaroiu, I.A.; Ionescu, D.; Balcangiu-Stroescu, A.-E. Cardiovascular Calcifications Are Correlated with Inflammation in Hemodialysis Patients. Medicina 2023, 59, 1801–1810. [Google Scholar] [CrossRef] [PubMed]
- Fanadka, F.; Rozenberg, I.; Nacasch, N.; Einbinder, Y.; Benchetrit, S.; Wand, O.; Hod, T.; Cohen-Hagai, K. Intra-Cranial Arterial Calcifications in Hemodialysis Patients. Medicina 2023, 59, 1706–1716. [Google Scholar] [CrossRef] [PubMed]
- Wu, T.-J.; Wang, C.-H.; Lai, Y.-H.; Kuo, C.-H.; Lin, Y.-L.; Hsu, B.-G. Serum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis. Medicina 2024, 60, 984–997. [Google Scholar] [CrossRef] [PubMed]
- Šafer, M.; Feldi, I.; Šahinović, I.; Tolj, I.; Pirić, M.; Šojat, D.; Oštarijaš, E.; Mihaljević, D. Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study. Medicina 2025, 61, 991–1005. [Google Scholar] [CrossRef] [PubMed]
- Venegas-Ramírez, J.; Hernández-Fuentes, G.A.; Palomares, C.S.; Diaz-Martinez, J.; Navarro-Cuellar, J.I.; Calvo-Soto, P.; Duran, C.; Tapia-Vargas, R.; Espíritu-Mojarro, A.C.; Figueroa-Gutiérrez, A.; et al. Vascular Access Type and Survival Outcomes in Hemodialysis Patients: A Seven-Year Cohort Study. Medicina 2025, 61, 584–598. [Google Scholar] [CrossRef] [PubMed]
- Domjanović Matetić, J.; Baković Kramarić, D.; Domjanović Škopinić, T.; Jeličić, I.; Borić Škaro, D.; Božić, J.; Matetić, A. Echocardiographic Indices in Patients with End-Stage Renal Disease and Their Association with Hemodialysis-to-Hemodiafiltration Transfer: A Prospective Observational Study. Medicina 2024, 60, 1537–1552. [Google Scholar] [CrossRef] [PubMed]
- Dimitrijevic, Z.M.; Mitic, B.P.; Tasic, D.D.; Vrecic, T.; Paunovic, K.; Salinger, S. Bleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study. Medicina 2024, 60, 1760–1774. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cohen-Hagai, K. Cardiovascular Disease and Hemodialysis. Medicina 2025, 61, 1796. https://doi.org/10.3390/medicina61101796
Cohen-Hagai K. Cardiovascular Disease and Hemodialysis. Medicina. 2025; 61(10):1796. https://doi.org/10.3390/medicina61101796
Chicago/Turabian StyleCohen-Hagai, Keren. 2025. "Cardiovascular Disease and Hemodialysis" Medicina 61, no. 10: 1796. https://doi.org/10.3390/medicina61101796
APA StyleCohen-Hagai, K. (2025). Cardiovascular Disease and Hemodialysis. Medicina, 61(10), 1796. https://doi.org/10.3390/medicina61101796